About this trial
Many patients are considering the use of so-called "hypnosis" treatments in the field of addictions. However, these techniques lack sufficient levels of evidence with regard to the standards required by Evidence-Based Medicine.
In other domains, however, hypnosis has demonstrated an interesting level of evidence, particularly in pain management.
The investigators will focus on the "Techniques for Activating Consciousness" (TAC), which represent an optimized therapeutic approach derived from hypnotic therapy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients consulting for an alcohol-related addiction problem at the CSAPA of Versailles (sites in Versailles, Trappes, Rambouillet) or at the Centre Hospitalier des 4 Villes (day hospital or CSAPA in Sèvres)
Patients must meet at least 4 of the 11 DSM-5 criteria (Annex 2), corresponding to moderate to severe addiction
Patients must be affiliated with the French social security system
Disqualifiers
Refusal to participate
Presence at inclusion of delusional, dissociative, and/or persecutory symptoms
Presence at inclusion of hypomanic or manic decompensation
Severe cognitive impairment, evidenced by inability to perform the clock-drawing test (draw the clock face, place the numbers, and set the hands to 11:10)
Trial design
Parallel
Treatments tested in this trial
TAC intervention
BehavioralPatients receiving TAC (Techniques for Activating Consciousness) intervention in addition to standard care
Treatment groups
Trial outcomes
Primary outcomes
The patient's ability to control alcohol consumption during outpatient follow-up in a CSAPA
The main outcome measure will be the number of weeks to achieve the targeted goal between T0 (first consultation when the objective is set) and M6 (cumulative time).
Secondary outcomes
Controlling addictive behavior in both groups
Evaluation criteria for both groups: * Cumulative time over 12 months during which the subject meets the target of controlling addictive behavior; percentage of time at target between T0-M6 and T0-M12; number of weeks to reach the target; number of relapses between T0-M6 and T0-M12; time between achieving the target and relapse between T0-M12 * Craving intensity (weekly via electronic patient questionnaire) * Levels of anxiety and depression (HAD scale) and global relaxation (IERS-3), at T0, M6, and M12 * Care received (interventions, medications) from medical records at M6 and M12 * Patient opinion questionnaire at M6 and M12 on what was perceived as useful or not in their treatment
Evaluation criteria for the TAC group
Weekly self-reports (via electronic patient questionnaire) on the frequency of exercise practice, perceived effectiveness of TAC (Techniques for Activating Consciousness) on their addictive issues (VAS 0-10), and tolerance of TAC (Techniques for Activating Consciousness)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: